Any feedback?
Please rate this page
(enzyme.php)
(0/150)

BRENDA support

Disease on EC 6.2.1.3 - long-chain-fatty-acid-CoA ligase and Organism(s) Homo sapiens and UniProt Accession O95573

Please use the Disease Search for a specific query.
Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
DISEASE
TITLE OF PUBLICATION
LINK TO PUBMED
Acidosis
Extracellular Acidosis Modulates the Expression of Epithelial-Mesenchymal Transition (EMT) Markers and Adhesion of Epithelial and Tumor Cells.
Promotion of glioma cell survival by acyl-CoA synthetase 5 under extracellular acidosis conditions.
Acquired Immunodeficiency Syndrome
Preservation of Acyl Coenzyme A Attenuates Pathological and Metabolic Cardiac Remodeling Through Selective Lipid Trafficking.
Adenocarcinoma
Impaired expression of acyl-CoA synthetase 5 in sporadic colorectal adenocarcinomas.
Low acyl-CoA synthetase 5 expression in colorectal carcinomas is prognostic for early tumour recurrence.
Adenocarcinoma of Lung
Roles of acyl-CoA synthetase long-chain family member 5 and colony stimulating factor 2 in inhibition of palmitic or stearic acids in lung cancer cell proliferation and metabolism.
Adrenoleukodystrophy
A mouse model for X-linked adrenoleukodystrophy.
A very long-chain acyl-CoA synthetase-deficient mouse and its relevance to X-linked adrenoleukodystrophy.
Adrenoleukodystrophy protein enhances association of very long-chain acyl-coenzyme A synthetase with the peroxisome.
Adrenoleukodystrophy: impaired oxidation of fatty acids due to peroxisomal lignoceroyl-CoA ligase deficiency.
cDNA cloning and mRNA distribution of a mouse very long-chain acyl-CoA synthetase.
Disruption of the Saccharomyces cerevisiae FAT1 gene decreases very long-chain fatty acyl-CoA synthetase activity and elevates intracellular very long-chain fatty acid concentrations.
Effect of clofibrate on peroxisomal lignoceroyl-CoA ligase activity.
Expression of an acyl-CoA synthetase, lipidosin, in astrocytes of the murine brain and its up-regulation during remyelination following cuprizone-induced demyelination.
Lessons from the gonadotropin-regulated long chain acyl-CoA synthetase (GR-LACS) null mouse model: a role in steroidogenesis, but not result in X-ALD phenotype.
Molecular organization of peroxisomal enzymes: protein-protein interactions in the membrane and in the matrix.
Mouse very long-chain acyl-CoA synthetase in X-linked adrenoleukodystrophy.
Novel acyl-CoA synthetase in adrenoleukodystrophy target tissues.
Peroxisomal activation of long- and very long-chain fatty acids in the yeast Pichia pastoris.
Peroxisomal fatty acid beta-oxidation in relation to the accumulation of very long chain fatty acids in cultured skin fibroblasts from patients with Zellweger syndrome and other peroxisomal disorders.
Prenatal diagnosis of Zellweger syndrome by measurement of very long chain fatty acid (C26:0) beta-oxidation in cultured chorionic villous fibroblasts: implications for early diagnosis of other peroxisomal disorders.
The red-green visual pigment gene region in adrenoleukodystrophy.
X-linked adrenoleukodystrophy: identification of the primary defect at the level of a deficient peroxisomal very long chain fatty acyl-CoA synthetase using a newly developed method for the isolation of peroxisomes from skin fibroblasts.
X-linked adrenoleukodystrophy: role of very long-chain acyl-CoA synthetases.
[Examination of very long chain fatty acids in diagnosis of x-linked adrenoleukodystrophy]
Amyotrophic Lateral Sclerosis
A multi-ethnic meta-analysis identifies novel genes, including ACSL5, associated with amyotrophic lateral sclerosis.
Asthma
Relation of DNA methylation of 5'-CpG island of ACSL3 to transplacental exposure to airborne polycyclic aromatic hydrocarbons and childhood asthma.
Atherosclerosis
Diabetes promotes an inflammatory macrophage phenotype and atherosclerosis through acyl-CoA synthetase 1.
Genetic association of long-chain acyl-CoA synthetase 1 variants with fasting glucose, diabetes, and subclinical atherosclerosis.
High expression of long chain acyl-coenzyme A synthetase 1 in peripheral blood may be a molecular marker for assessing the risk of acute myocardial infarction.
Inflammation and diabetes-accelerated atherosclerosis: myeloid cell mediators.
Liver-specific ATP-citrate lyase inhibition by bempedoic acid decreases LDL-C and attenuates atherosclerosis.
Blindness
Inverse correlation between fatty acid transport protein 4 and vision in Leber congenital amaurosis associated with RPE65 mutation.
Brain Neoplasms
Lipid metabolism enzyme ACSVL3 supports glioblastoma stem cell maintenance and tumorigenicity.
Breast Neoplasms
ACSL1 Regulates TNF?-Induced GM-CSF Production by Breast Cancer MDA-MB-231 Cells.
An Evaluation of Fatty Acid-CoA Ligase 4 in Breast Cancer.
Association of long-chain acyl-coenzyme A synthetase 5 expression in human breast cancer by estrogen receptor status and its clinical significance.
Creatine-mediated crosstalk between adipocytes and cancer cells regulates obesity-driven breast cancer.
Evaluation of long-chain acyl-coenzyme A synthetase 4 (ACSL4) expression in human breast cancer.
Expression of Long-chain Fatty Acyl-CoA Synthetase 4 in Breast and Prostate Cancers Is Associated with Sex Steroid Hormone Receptor Negativity.
Fatty acid-binding protein 5 (FABP5) promotes lipolysis of lipid droplets, de novo fatty acid (FA) synthesis and activation of nuclear factor-kappa B (NF-?B) signaling in cancer cells.
Functional interaction between acyl-CoA synthetase 4, lipooxygenases and cyclooxygenase-2 in the aggressive phenotype of breast cancer cells.
HBXIP up-regulates ACSL1 through activating transcriptional factor Sp1 in breast cancer.
Long chain fatty Acyl-CoA synthetase 4 is a biomarker for and mediator of hormone resistance in human breast cancer.
LPS Induces GM-CSF Production by Breast Cancer MDA-MB-231 Cells via Long-Chain Acyl-CoA Synthetase 1.
Regulatory mechanisms leading to differential Acyl-CoA synthetase 4 expression in breast cancer cells.
Systematic Analysis of Gene Expression Alterations and Clinical Outcomes for Long-Chain Acyl-Coenzyme A Synthetase Family in Cancer.
The endogenous subcellular localisations of the long chain fatty acid-activating enzymes ACSL3 and ACSL4 in sarcoma and breast cancer cells.
Carcinogenesis
Differentially localized acyl-CoA synthetase 4 isoenzymes mediate the metabolic channeling of fatty acids towards phosphatidylinositol.
Fatty acid activation in carcinogenesis and cancer development: Essential roles of long-chain acyl-CoA synthetases.
Fatty Acid Oxidation Mediated by Acyl-CoA Synthetase Long Chain 3 Is Required for Mutant KRAS Lung Tumorigenesis.
High Membranous Expression of Fatty Acid Transport Protein 4 Is Associated with Tumorigenesis and Tumor Progression in Clear Cell Renal Cell Carcinoma.
Involvement of fatty acid-CoA ligase 4 in hepatocellular carcinoma growth: roles of cyclic AMP and p38 mitogen-activated protein kinase.
Lipid metabolism enzyme ACSVL3 supports glioblastoma stem cell maintenance and tumorigenicity.
Low acyl-CoA synthetase 5 expression in colorectal carcinomas is prognostic for early tumour recurrence.
TP53 status regulates ACSL5-induced expression of mitochondrial mortalin in enterocytes and colorectal adenocarcinomas.
Wnt Lipidation and Modifiers in Intestinal Carcinogenesis and Cancer.
Carcinoma
ACSL family: The regulatory mechanisms and therapeutic implications in cancer.
High Membranous Expression of Fatty Acid Transport Protein 4 Is Associated with Tumorigenesis and Tumor Progression in Clear Cell Renal Cell Carcinoma.
Levels of acyl-coenzyme A synthetase 5 in urothelial cells and corresponding neoplasias reflect cellular differentiation.
Carcinoma, Endometrioid
Expression of acyl-CoA synthetase 5 in human endometrium and in endometrioid adenocarcinomas.
Carcinoma, Hepatocellular
Activation of AMP-kinase by Policosanol Requires Peroxisomal Metabolism.
Expression of putative fatty acid transporter genes are regulated by peroxisome proliferator-activated receptor alpha and gamma activators in a tissue- and inducer-specific manner.
Fatty acid-CoA ligase 4 is overexpressed in human hepatocellular carcinoma.
Functional interaction between acyl-CoA synthetase 4, lipooxygenases and cyclooxygenase-2 in the aggressive phenotype of breast cancer cells.
Immunohistochemical staining reveals differential expression of ACSL3 and ACSL4 in hepatocellular carcinoma and hepatic gastrointestinal metastases.
Involvement of fatty acid-CoA ligase 4 in hepatocellular carcinoma growth: roles of cyclic AMP and p38 mitogen-activated protein kinase.
Long chain acyl-CoA synthetase 3-mediated phosphatidylcholine synthesis is required for assembly of very low density lipoproteins in human hepatoma Huh7 cells.
Long Noncoding RNA HULC Modulates Abnormal Lipid Metabolism in Hepatoma Cells through an miR-9-Mediated RXRA Signaling Pathway.
MiR-205 modulates abnormal lipid metabolism of hepatoma cells via targeting acyl-CoA synthetase long-chain family member 1 (ACSL1) mRNA.
New actions of melatonin on tumor metabolism and growth.
Overexpression of acyl-CoA synthetase-1 increases lipid deposition in hepatic (HepG2) cells and rodent liver in vivo.
Overexpression of CD36 and acyl-CoA synthetases FATP2, FATP4 and ACSL1 increases fatty acid uptake in human hepatoma cells.
Rat long chain acyl-CoA synthetase 5 increases fatty acid uptake and partitioning to cellular triacylglycerol in McArdle-RH7777 cells.
Regulation of cell growth by fatty acid-CoA ligase 4 in human hepatocellular carcinoma cells.
The functional interaction between Acyl-CoA synthetase 4, 5-lipooxygenase and cyclooxygenase-2 controls tumor growth: a novel therapeutic target.
Carcinoma, Non-Small-Cell Lung
ACSL family: The regulatory mechanisms and therapeutic implications in cancer.
Metabolic enzyme ACSL3 is a prognostic biomarker and correlates with anticancer effectiveness of statins in non-small cell lung cancer.
Carcinoma, Renal Cell
High Membranous Expression of Fatty Acid Transport Protein 4 Is Associated with Tumorigenesis and Tumor Progression in Clear Cell Renal Cell Carcinoma.
Cardiomegaly
Cardiac energy dependence on glucose increases metabolites related to glutathione and activates metabolic genes controlled by mechanistic target of rapamycin.
Deficiency of cardiac Acyl-CoA synthetase-1 induces diastolic dysfunction, but pathologic hypertrophy is reversed by rapamycin.
Metabolic activation and major protein target of a 1-benzyl-3-carboxyazetidine sphingosine-1-phosphate-1 receptor agonist.
Mouse cardiac acyl coenzyme a synthetase 1 deficiency impairs Fatty Acid oxidation and induces cardiac hypertrophy.
Cardiomyopathies
A novel mouse model of lipotoxic cardiomyopathy.
DGAT1 expression increases heart triglyceride content but ameliorates lipotoxicity.
Fatty acid transport proteins in disease: New insights from invertebrate models.
Transgenic expression of fatty acid transport protein 1 in the heart causes lipotoxic cardiomyopathy.
Cardiovascular Diseases
Can high-intensity interval training improve physical and mental health outcomes? A meta-review of 33 systematic reviews across the lifespan.
Cholangiocarcinoma
Immunohistochemical staining reveals differential expression of ACSL3 and ACSL4 in hepatocellular carcinoma and hepatic gastrointestinal metastases.
Cholelithiasis
FATP2-targeted therapies - A role beyond fatty liver disease.
Prevention of gallbladder hypomotility via FATP2 inhibition protects from lithogenic diet-induced cholelithiasis.
Colitis, Ulcerative
Alterations in intestinal fatty acid metabolism in inflammatory bowel disease.
Colonic Neoplasms
3'UTR Polymorphism in ACSL1 Gene Correlates with Expression Levels and Poor Clinical Outcome in Colon Cancer Patients.
ColoLipidGene: signature of lipid metabolism-related genes to predict prognosis in stage-II colon cancer patients.
Fatty acid CoA ligase 4 is up-regulated in colon adenocarcinoma.
Involvement of fatty acid-CoA ligase 4 in hepatocellular carcinoma growth: roles of cyclic AMP and p38 mitogen-activated protein kinase.
Overexpression of DHX32 contributes to the growth and metastasis of colorectal cancer.
Systematic Analysis of Gene Expression Alterations and Clinical Outcomes for Long-Chain Acyl-Coenzyme A Synthetase Family in Cancer.
Colorectal Neoplasms
ACSL family: The regulatory mechanisms and therapeutic implications in cancer.
Acyl-CoA Synthetase 5 Promotes the Growth and Invasion of Colorectal Cancer Cells.
Low acyl-CoA synthetase 5 expression in colorectal carcinomas is prognostic for early tumour recurrence.
miR-497-5p mediates starvation-induced death in colon cancer cells by targeting acyl-CoA synthetase-5 and modulation of lipid metabolism.
Coma
Analysis of the role of COMATOSE and peroxisomal beta-oxidation in the determination of germination potential in Arabidopsis.
Arabidopsis SFAR4 is a novel GDSL-type esterase involved in fatty acid degradation and glucose tolerance.
Coronary Artery Disease
Can high-intensity interval training improve physical and mental health outcomes? A meta-review of 33 systematic reviews across the lifespan.
Coronary Disease
Can high-intensity interval training improve physical and mental health outcomes? A meta-review of 33 systematic reviews across the lifespan.
Crohn Disease
Expression of acyl-CoA synthetase 5 reflects the state of villus architecture in human small intestine.
Dehydration
Epidermal hyperproliferation in mice lacking fatty acid transport protein 4 (FATP4) involves ectopic EGF receptor and STAT3 signaling.
Fatty acid transport protein 1 can compensate for fatty acid transport protein 4 in the developing mouse epidermis.
Keratinocyte-specific expression of fatty acid transport protein 4 rescues the wrinkle-free phenotype in Slc27a4/Fatp4 mutant mice.
Requirement of fatty acid transport protein 4 for development, maturation, and function of sebaceous glands in a mouse model of ichthyosis prematurity syndrome.
Demyelinating Diseases
Expression of an acyl-CoA synthetase, lipidosin, in astrocytes of the murine brain and its up-regulation during remyelination following cuprizone-induced demyelination.
Diabetes Mellitus
Can high-intensity interval training improve physical and mental health outcomes? A meta-review of 33 systematic reviews across the lifespan.
FATP2-targeted therapies - A role beyond fatty liver disease.
Diabetes Mellitus, Type 1
Diabetes promotes an inflammatory macrophage phenotype and atherosclerosis through acyl-CoA synthetase 1.
Inflammation and diabetes-accelerated atherosclerosis: myeloid cell mediators.
Diabetes Mellitus, Type 2
Can high-intensity interval training improve physical and mental health outcomes? A meta-review of 33 systematic reviews across the lifespan.
FATP2-targeted therapies - A role beyond fatty liver disease.
Increased hepatic CD36 expression contributes to dyslipidemia associated with diet-induced obesity.
Skeletal muscle fatty acid transporter protein expression in type 2 diabetes patients compared with overweight, sedentary men and age-matched, endurance-trained cyclists.
The type 2 diabetes presumed causal variant within TCF7L2 resides in an element that controls the expression of ACSL5.
Diabetes, Gestational
Gestational diabetes mellitus decreases placental uptake of long-chain polyunsaturated fatty acids: involvement of long-chain acyl-CoA synthetase.
Diabetic Angiopathies
Inflammation and diabetes-accelerated atherosclerosis: myeloid cell mediators.
Diabetic Nephropathies
HMGB1 regulates ferroptosis through Nrf2 pathway in mesangial cells in response to high glucose.
Dyslipidemias
Increased hepatic CD36 expression contributes to dyslipidemia associated with diet-induced obesity.
Erythema
Association of a long-chain fatty acid-CoA ligase 4 gene polymorphism with depression and with enhanced niacin-induced dermal erythema.
Fatty Liver
Alteration of Hepatic Gene Expression along with the Inherited Phenotype of Acquired Fatty Liver in Chicken.
ApoB siRNA-induced Liver Steatosis is Resistant to Clearance by the Loss of Fatty Acid Transport Protein 5 (Fatp5).
Bile acids mediated potential functional interaction between FXR and FATP5 in the regulation of Lipid Metabolism.
Low Expression of Sirtuin 1 in the Dairy Cows with Mild Fatty Liver Alters Hepatic Lipid Metabolism.
Molecular cloning of the goose ACSL3 and ACSL5 coding domain sequences and their expression characteristics during goose fatty liver development.
Osthole improves fat milk-induced fatty liver in rats: modulation of hepatic PPAR-alpha/gamma-mediated lipogenic gene expression.
Prevention Mechanism of 2,3,5,4'-Tetrahydroxy-stilbene-2-O-?-D-glucoside on Lipid Accumulation in Steatosis Hepatic L-02 Cell.
Regular exposure to non-burning ultraviolet radiation reduces signs of non-alcoholic fatty liver disease in mature adult mice fed a high fat diet: results of a pilot study.
Silencing of hepatic fatty acid transporter protein 5 in vivo reverses diet-induced non-alcoholic fatty liver disease and improves hyperglycemia.
[The expression and the significance of L-FABP and FATP4 in the development of nonalcoholic fatty liver disease in rats]
Fibrosarcoma
The endogenous subcellular localisations of the long chain fatty acid-activating enzymes ACSL3 and ACSL4 in sarcoma and breast cancer cells.
Gallstones
Prevention of gallbladder hypomotility via FATP2 inhibition protects from lithogenic diet-induced cholelithiasis.
Glioblastoma
Very long-chain acyl-CoA synthetase 3 mediates onco-sphingolipid metabolism in malignant glioma.
Very long-chain acyl-CoA synthetase 3: overexpression and growth dependence in lung cancer.
Glioma
Acyl-CoA synthetase as a cancer survival factor: its inhibition enhances the efficacy of etoposide.
Acyl-CoA synthetase VL3 knockdown inhibits human glioma cell proliferation and tumorigenicity.
Fatty acid induced glioma cell growth is mediated by the acyl-CoA synthetase 5 gene located on chromosome 10q25.1-q25.2, a region frequently deleted in malignant gliomas.
Integrated metabolomics and lipidomics analyses reveal metabolic reprogramming in human glioma with IDH1 mutation.
Promotion of glioma cell survival by acyl-CoA synthetase 5 under extracellular acidosis conditions.
Very long-chain acyl-CoA synthetase 3 mediates onco-sphingolipid metabolism in malignant glioma.
Very long-chain acyl-CoA synthetase 3: overexpression and growth dependence in lung cancer.
Granuloma
Caseation of human tuberculosis granulomas correlates with elevated host lipid metabolism.
Hepatitis B
MiR-205 modulates abnormal lipid metabolism of hepatoma cells via targeting acyl-CoA synthetase long-chain family member 1 (ACSL1) mRNA.
Hypercholesterolemia
Inhibition of miR-27b Regulates Lipid Metabolism in Skeletal Muscle of Obese Rats During Hypoxic Exercise by Increasing PPAR? Expression.
Hyperglycemia
The signaling mechanisms of hippocampal endoplasmic reticulum stress affecting neuronal plasticity-related protein levels in high fat diet-induced obese rats and the regulation of aerobic exercise.
Transcriptome Changes of Skeletal Muscle RNA-Seq Speculates the Mechanism of Postprandial Hyperglycemia in Diabetic Goto-Kakizaki Rats During the Early Stage of T2D.
Hyperlipidemias
Elevation of blood lipids in hepatocyte-specific fatty acid transport 4-deficient mice fed with high glucose diets.
The signaling mechanisms of hippocampal endoplasmic reticulum stress affecting neuronal plasticity-related protein levels in high fat diet-induced obese rats and the regulation of aerobic exercise.
Hypersensitivity
Long-Chain acyl-CoA Synthetase LACS2 Contributes to Submergence Tolerance by Modulating Cuticle Permeability in Arabidopsis.
Hyperthyroidism
Effects of experimental hypo- and hyperthyroidism on hepatic long-chain fatty acyl-CoA synthetase and hydrolase.
Hypertriglyceridemia
Transcriptional activation of hepatic ACSL3 and ACSL5 by oncostatin m reduces hypertriglyceridemia through enhanced beta-oxidation.
Hypertrophy, Left Ventricular
A variant in the heart-specific fatty acid transport protein 6 is associated with lower fasting and postprandial TAG, blood pressure and left ventricular hypertrophy.
Ichthyosis
A spontaneous Fatp4/Scl27a4 splice site mutation in a new murine model for congenital ichthyosis.
Epidermal hyperproliferation in mice lacking fatty acid transport protein 4 (FATP4) involves ectopic EGF receptor and STAT3 signaling.
FATP4 missense and nonsense mutations cause similar features in Ichthyosis Prematurity Syndrome.
Fatty acid transport protein 1 can compensate for fatty acid transport protein 4 in the developing mouse epidermis.
Fatty acid transport protein 4 is required for incorporation of saturated ultralong-chain fatty acids into epidermal ceramides and monoacylglycerols.
Fatty acid transporters in skin development, function and disease.
Ichthyosis prematurity syndrome caused by a novel fatty acid transport protein 4 gene mutation in a German infant.
Ichthyosis prematurity syndrome caused by a novel missense mutation in FATP4 gene-a case report from India.
Ichthyosis prematurity syndrome in two Omani siblings, caused by homozygous c.1A > G mutation in the FATP4 gene.
Identification of novel FATP4 mutations in a Japanese patient with ichthyosis prematurity syndrome.
Impacts of deletion and ichthyosis prematurity syndrome-associated mutations in fatty acid transport protein 4 on the function of RPE65.
Interactions between FATP4 and ichthyin in epidermal lipid processing may provide clues to the pathogenesis of autosomal recessive congenital ichthyosis.
Mutations in the fatty acid transport protein 4 gene cause the ichthyosis prematurity syndrome.
Novel compound heterozygous FATP4 mutations caused ichthyosis prematurity syndrome in Spanish sisters.
Novel mutations in FATP4 gene in two families with ichthyosis prematurity syndrome.
Requirement of fatty acid transport protein 4 for development, maturation, and function of sebaceous glands in a mouse model of ichthyosis prematurity syndrome.
Role of fatty acid transporters in epidermis: Implications for health and disease.
[Ichthyosis prematurity syndrome: Two new cases].
Infections
Enzymatic properties of purified murine fatty acid transport protein 4 and analysis of acyl-CoA synthetase activities in tissues from FATP4 null mice.
Long chain acyl-CoA synthetase 3-mediated phosphatidylcholine synthesis is required for assembly of very low density lipoproteins in human hepatoma Huh7 cells.
Microarray analysis reveals the inhibition of intestinal expression of nutrient transporters in piglets infected with porcine epidemic diarrhea virus.
Modulation of triglyceride and cholesterol ester synthesis impairs assembly of infectious hepatitis C virus.
Reduction of serum free fatty acids and triglycerides by liver-targeted expression of long chain acyl-CoA synthetase 3.
Infertility
Activity of Long-Chain Acyl-CoA Synthetase Is Required for Maintaining Meiotic Arrest in Xenopus laevis.
Infertility, Male
Acyl-CoA synthetase 6 regulates long-chain polyunsaturated fatty acid composition of membrane phospholipids in spermatids and supports normal spermatogenic processes in mice.
Insulin Resistance
A null mutation in skeletal muscle FAT/CD36 reveals its essential role in insulin- and AICAR-stimulated fatty acid metabolism.
ACSL1 Is Associated With Fetal Programming of Insulin Sensitivity and Cellular Lipid Content.
Acyl CoA synthetase 5 (ACSL5) ablation in mice increases energy expenditure and insulin sensitivity and delays fat absorption.
An Essential Role of the N-Terminal Region of ACSL1 in Linking Free Fatty Acids to Mitochondrial ?-Oxidation in C2C12 Myotubes.
Effects of Periconception Cadmium and Mercury Co-Administration to Mice on Indices of Chronic Diseases in Male Offspring at Maturity.
Expression of fatty-acid-handling proteins in human adipose tissue in relation to obesity and insulin resistance.
Fatty acid handling protein expression in adipose tissue, fatty acid composition of adipose tissue and serum, and markers of insulin resistance.
Fatty acid transport proteins and insulin resistance.
Fatty acid transport proteins.
Fatty Acid Transport Proteins: Targeting FATP2 as a Gatekeeper Involved in the Transport of Exogenous Fatty Acids.
Functional analysis of long-chain acyl-coa synthetase 1 in 3T3-L1 adipocytes.
Genetic and structural evaluation of fatty acid transport protein-4 in relation to markers of the insulin resistance syndrome.
Inactivation of fatty acid transport protein 1 prevents fat-induced insulin resistance in skeletal muscle.
Increasing skeletal muscle fatty acid transport protein 1 (FATP1) targets fatty acids to oxidation and does not predispose mice to diet-induced insulin resistance.
Palmitate activation by fatty acid transport protein 4 as a model system for hepatocellular apoptosis and steatosis.
SUMO-Specific Protease 2 (SENP2) Is an Important Regulator of Fatty Acid Metabolism in Skeletal Muscle.
Intellectual Disability
A third MRX family (MRX68) is the result of mutation in the long chain fatty acid-CoA ligase 4 (FACL4) gene: proposal of a rapid enzymatic assay for screening mentally retarded patients.
Acsl, the Drosophila ortholog of intellectual-disability-related ACSL4, inhibits synaptic growth by altered lipids.
dAcsl, the Drosophila ortholog of acyl-CoA synthetase long-chain family member 3 and 4, inhibits synapse growth by attenuating bone morphogenetic protein signaling via endocytic recycling.
Drosophila homolog of the intellectual disability-related long-chain acyl-CoA synthetase 4 is required for neuroblast proliferation.
FACL4, a new gene encoding long-chain acyl-CoA synthetase 4, is deleted in a family with Alport syndrome, elliptocytosis, and mental retardation.
No association between polymorphisms in the FACL4 (fatty acid-CoA ligase 4) gene and nonspecific mental retardation in Qin-Ba mountain region of China.
Ischemic Stroke
Inhibition of Acyl-CoA Synthetase Long-Chain Family Member 4 Facilitates Neurological Recovery After Stroke by Regulation Ferroptosis.
Leber Congenital Amaurosis
Inverse correlation between fatty acid transport protein 4 and vision in Leber congenital amaurosis associated with RPE65 mutation.
Leiomyosarcoma
The endogenous subcellular localisations of the long chain fatty acid-activating enzymes ACSL3 and ACSL4 in sarcoma and breast cancer cells.
Leukemia
Identification of novel lipid droplet factors that regulate lipophagy and cholesterol efflux in macrophage foam cells.
Leukemia, Lymphoid
Eight genes are highly associated with BMD variation in postmenopausal Caucasian women.
Leukemia, Myeloid, Acute
Systematic Analysis of Gene Expression Alterations and Clinical Outcomes for Long-Chain Acyl-Coenzyme A Synthetase Family in Cancer.
Leukemia, T-Cell
Identification of novel lipid droplet factors that regulate lipophagy and cholesterol efflux in macrophage foam cells.
Lipid Metabolism Disorders
Generation of Acsl4 Gene Knockout Mouse Model by CRISPR/Cas9-Mediated Genome Engineering.
Liver Cirrhosis
MicroRNA-34a Promotes Hepatic Stellate Cell Activation via Targeting ACSL1.
MiR-34c promotes hepatic stellate cell activation and Liver Fibrogenesis by suppressing ACSL1 expression.
Liver Diseases
Bile acids mediated potential functional interaction between FXR and FATP5 in the regulation of Lipid Metabolism.
FATP2 is a hepatic fatty acid transporter and peroxisomal very long-chain acyl-CoA synthetase.
FATP2-targeted therapies - A role beyond fatty liver disease.
Prevention Mechanism of 2,3,5,4'-Tetrahydroxy-stilbene-2-O-?-D-glucoside on Lipid Accumulation in Steatosis Hepatic L-02 Cell.
Silencing of hepatic fatty acid transporter protein 5 in vivo reverses diet-induced non-alcoholic fatty liver disease and improves hyperglycemia.
TXNIP/VDUP1 attenuates steatohepatitis via autophagy and fatty acid oxidation.
[The expression and the significance of L-FABP and FATP4 in the development of nonalcoholic fatty liver disease in rats]
Liver Neoplasms
MiR-205 modulates abnormal lipid metabolism of hepatoma cells via targeting acyl-CoA synthetase long-chain family member 1 (ACSL1) mRNA.
The effect of fatty acid-CoA ligase 4 on the growth of hepatic cancer cells.
long-chain-fatty-acid-coa ligase deficiency
Abnormal uterus with polycysts, accumulation of uterine prostaglandins, and reduced fertility in mice heterozygous for acyl-CoA synthetase 4 deficiency.
Acyl-CoA Synthetase 1 is Induced by Gram-Negative Bacteria and Lipopolysaccharide and is Required for Phospholipid Turnover in Stimulated Macrophages.
Adipocyte-specific inactivation of the acyl-CoA-synthetase fatty acid transport protein 4 (Fatp4) in mice causes adipose hypertrophy and alterations in metabolism of complex lipids under high-fat diet.
Compartmentalized acyl-CoA metabolism in skeletal muscle regulates systemic glucose homeostasis.
Defective fatty acid oxidation in mice with muscle-specific acyl-CoA synthetase 1 deficiency increases amino acid use and impairs muscle function.
Disturbed epidermal structure in mice with temporally controlled fatp4 deficiency.
Fatty acid transport protein 4 is the principal very long chain fatty acyl-CoA synthetase in skin fibroblasts.
Fatty acid transporters in skin development, function and disease.
Identification of a novel function of hepatic long-chain acyl-CoA synthetase-1 (ACSL1) in bile acid synthesis and its regulation by bile acid-activated farnesoid X receptor.
Methionine- and Choline-Deficient Diet Enhances Adipose Lipolysis and Leptin Release in aP2-Cre Fatp4-Knockout Mice.
Mutations in the fatty acid transport protein 4 gene cause the ichthyosis prematurity syndrome.
Lung Neoplasms
Fatty Acid Oxidation Mediated by Acyl-CoA Synthetase Long Chain 3 Is Required for Mutant KRAS Lung Tumorigenesis.
Metabolic enzyme ACSL3 is a prognostic biomarker and correlates with anticancer effectiveness of statins in non-small cell lung cancer.
MicroRNA-Dependent Regulation of Transcription in Non-Small Cell Lung Cancer.
Roles of acyl-CoA synthetase long-chain family member 5 and colony stimulating factor 2 in inhibition of palmitic or stearic acids in lung cancer cell proliferation and metabolism.
Systematic Analysis of Gene Expression Alterations and Clinical Outcomes for Long-Chain Acyl-Coenzyme A Synthetase Family in Cancer.
The ACSL3-LPIAT1 signaling drives prostaglandin synthesis in non-small cell lung cancer.
Very long-chain acyl-CoA synthetase 3: overexpression and growth dependence in lung cancer.
Lupus Erythematosus, Systemic
High ACSL5 transcript levels associate with systemic lupus erythematosus and apoptosis in Jurkat T lymphocytes and peripheral blood cells.
Melanoma
ACSL family: The regulatory mechanisms and therapeutic implications in cancer.
Changes in Aged Fibroblast Lipid Metabolism Induce Age-Dependent Melanoma Cell Resistance to Targeted Therapy via the Fatty Acid Transporter FATP2.
Systematic Analysis of Gene Expression Alterations and Clinical Outcomes for Long-Chain Acyl-Coenzyme A Synthetase Family in Cancer.
Mental Retardation, X-Linked
A third MRX family (MRX68) is the result of mutation in the long chain fatty acid-CoA ligase 4 (FACL4) gene: proposal of a rapid enzymatic assay for screening mentally retarded patients.
dAcsl, the Drosophila ortholog of acyl-CoA synthetase long-chain family member 3 and 4, inhibits synapse growth by attenuating bone morphogenetic protein signaling via endocytic recycling.
FACL4, encoding fatty acid-CoA ligase 4, is mutated in nonspecific X-linked mental retardation.
Metabolic Syndrome
A Promoter Polymorphism in the Liver-specific Fatty Acid Transport Protein 5 is Associated with Features of the Metabolic Syndrome and Steatosis.
Can high-intensity interval training improve physical and mental health outcomes? A meta-review of 33 systematic reviews across the lifespan.
Gene-nutrient interactions with dietary fat modulate the association between genetic variation of the ACSL1 gene and metabolic syndrome.
Migraine Disorders
A splice variant in the ACSL5 gene relates migraine with fatty acid activation in mitochondria.
Multiple Myeloma
Translocation t(11;14) (q13;q32) and genomic imbalances in multi-ethnic multiple myeloma patients: a Malaysian study.
Muscle Weakness
Defective fatty acid oxidation in mice with muscle-specific acyl-CoA synthetase 1 deficiency increases amino acid use and impairs muscle function.
Muscular Diseases
[Bempedoic acid: mechanism of action].
Myalgia
[Bempedoic acid: mechanism of action].
Myotoxicity
Liver-specific ATP-citrate lyase inhibition by bempedoic acid decreases LDL-C and attenuates atherosclerosis.
Neoplasm Metastasis
Characterization of the mouse promoter region of the acyl-CoA synthetase 4 gene: Role of Sp1 and CREB.
Immunohistochemical staining reveals differential expression of ACSL3 and ACSL4 in hepatocellular carcinoma and hepatic gastrointestinal metastases.
Metabolic reprogramming of ovarian cancer involves ACSL1-mediated metastasis stimulation through upregulated protein myristoylation.
Upregulation of Fatty Acid Transporters is Associated With Tumor Progression in Non-Muscle-Invasive Bladder Cancer.
Neoplasms
3'UTR Polymorphism in ACSL1 Gene Correlates with Expression Levels and Poor Clinical Outcome in Colon Cancer Patients.
ACSL family: The regulatory mechanisms and therapeutic implications in cancer.
ACSL1 Regulates TNF?-Induced GM-CSF Production by Breast Cancer MDA-MB-231 Cells.
ACSL3-PAI-1 signaling axis mediates tumor-stroma cross-talk promoting pancreatic cancer progression.
Activating Transcription Factor 6 Mediates Inflammatory Signals in Intestinal Epithelial Cells Upon Endoplasmic Reticulum Stress.
Acyl-CoA Synthetase 5 Promotes the Growth and Invasion of Colorectal Cancer Cells.
Acyl-CoA synthetase-4, a new regulator of mTOR and a potential therapeutic target for enhanced estrogen receptor function in receptor-positive and -negative breast cancer.
An Evaluation of Fatty Acid-CoA Ligase 4 in Breast Cancer.
BMP4 Upregulation Is Associated with Acquired Drug Resistance and Fatty Acid Metabolism in EGFR-Mutant Non-Small-Cell Lung Cancer Cells.
Can high-intensity interval training improve physical and mental health outcomes? A meta-review of 33 systematic reviews across the lifespan.
Changes in Aged Fibroblast Lipid Metabolism Induce Age-Dependent Melanoma Cell Resistance to Targeted Therapy via the Fatty Acid Transporter FATP2.
Characterization of the mouse promoter region of the acyl-CoA synthetase 4 gene: Role of Sp1 and CREB.
Creatine-mediated crosstalk between adipocytes and cancer cells regulates obesity-driven breast cancer.
Development and validation of a lipogenic genes panel for diagnosis and recurrence of colorectal cancer.
Expression and vitamin D(3) regulation of long-chain fatty-acid-CoA ligase 3 in human prostate cancer cells.
FATP2-targeted therapies - A role beyond fatty liver disease.
Fatty acid activation in carcinogenesis and cancer development: Essential roles of long-chain acyl-CoA synthetases.
Fatty acid transport protein 2 reprograms neutrophils in cancer.
Fatty Acids Corrupt Neutrophils in Cancer.
Ferroptosis-Related Genes in Lung Adenocarcinoma: Prognostic Signature and Immune, Drug Resistance, Mutation Analysis.
Ferroptotic cell death triggered by conjugated linolenic acids is mediated by ACSL1.
High Membranous Expression of Fatty Acid Transport Protein 4 Is Associated with Tumorigenesis and Tumor Progression in Clear Cell Renal Cell Carcinoma.
How to overcome the side effects of tumor immunotherapy.
Identification of ACSL4 as a biomarker and contributor of ferroptosis.
Identification of developmental competence-related genes in mature porcine oocytes.
Immunohistochemical staining reveals differential expression of ACSL3 and ACSL4 in hepatocellular carcinoma and hepatic gastrointestinal metastases.
Integrated metabolomics and lipidomics analyses reveal metabolic reprogramming in human glioma with IDH1 mutation.
Lack of association between certain candidate gene polymorphisms and the metabolic syndrome.
Levels of acyl-coenzyme A synthetase 5 in urothelial cells and corresponding neoplasias reflect cellular differentiation.
Long-Chain Acyl-CoA Synthetase 4-Mediated Fatty Acid Metabolism Sustains Androgen Receptor Pathway-Independent Prostate Cancer.
Long-chain fatty acyl-CoA synthetase 1 promotes prostate cancer progression by elevation of lipogenesis and fatty acid beta-oxidation.
Low acyl-CoA synthetase 5 expression in colorectal carcinomas is prognostic for early tumour recurrence.
LOX and ACSL5 as potential relapse markers for pancreatic cancer patients.
Metabolic reprogramming of ovarian cancer involves ACSL1-mediated metastasis stimulation through upregulated protein myristoylation.
Multigenerational maternal obesity increases the incidence of HCC in offspring via miR-27a-3p.
New inhibitor targeting Acyl-CoA synthetase 4 reduces breast and prostate tumor growth, therapeutic resistance and steroidogenesis.
Persistent activity modification of phosphatidate phosphohydrolase and fatty acyl-CoA synthetase on incubation of adipocytes with the tumour promoter 12-O-tetradecanoylphorbol 13-acetate.
Promotion of glioma cell survival by acyl-CoA synthetase 5 under extracellular acidosis conditions.
Regulation and role of Acyl-CoA synthetase 4 in glial cells.
Regulation of ROS in myeloid-derived suppressor cells through targeting fatty acid transport protein 2 enhanced anti-PD-L1 tumor immunotherapy.
Systematic Analysis of Gene Expression Alterations and Clinical Outcomes for Long-Chain Acyl-Coenzyme A Synthetase Family in Cancer.
Targeting Long Chain Acyl-CoA Synthetases for Cancer Therapy.
Targeting Oct1 genomic function inhibits androgen receptor signaling and castration-resistant prostate cancer growth.
The endogenous subcellular localisations of the long chain fatty acid-activating enzymes ACSL3 and ACSL4 in sarcoma and breast cancer cells.
The function of SNHG7/miR-449a/ACSL1 axis in thyroid cancer.
The functional interaction between Acyl-CoA synthetase 4, 5-lipooxygenase and cyclooxygenase-2 controls tumor growth: a novel therapeutic target.
TXNIP/VDUP1 attenuates steatohepatitis via autophagy and fatty acid oxidation.
Upregulation of Fatty Acid Transporters is Associated With Tumor Progression in Non-Muscle-Invasive Bladder Cancer.
Utilization of adipocyte-derived lipids and enhanced intracellular trafficking of fatty acids contribute to breast cancer progression.
Nephritis, Hereditary
FACL4, a new gene encoding long-chain acyl-CoA synthetase 4, is deleted in a family with Alport syndrome, elliptocytosis, and mental retardation.
Neuroblastoma
RNA interference of long-chain acyl-CoA synthetase 6 suppresses the neurite outgrowth of mouse neuroblastoma NB41A3 cells.
Neuroinflammatory Diseases
Acyl-CoA synthetase 6 is required for brain docosahexaenoic acid retention and neuroprotection during aging.
Non-alcoholic Fatty Liver Disease
Analysis of hepatic genes involved in the metabolism of fatty acids and iron in nonalcoholic fatty liver disease.
Beneficial effects of neomangiferin on high fat diet-induced nonalcoholic fatty liver disease in rats.
FATP2 is a hepatic fatty acid transporter and peroxisomal very long-chain acyl-CoA synthetase.
FATP2-targeted therapies - A role beyond fatty liver disease.
Genome-wide analysis of DNA methylation in human peripheral leukocytes identifies potential biomarkers of nonalcoholic fatty liver disease.
Prevention Mechanism of 2,3,5,4'-Tetrahydroxy-stilbene-2-O-?-D-glucoside on Lipid Accumulation in Steatosis Hepatic L-02 Cell.
Silencing of hepatic fatty acid transporter protein 5 in vivo reverses diet-induced non-alcoholic fatty liver disease and improves hyperglycemia.
TXNIP/VDUP1 attenuates steatohepatitis via autophagy and fatty acid oxidation.
[The expression and the significance of L-FABP and FATP4 in the development of nonalcoholic fatty liver disease in rats]
Obesity
Acute effects of epigallocatechin gallate from green tea on oxidation and tissue incorporation of dietary lipids in mice fed a high-fat diet.
Acyl CoA synthetase 5 (ACSL5) ablation in mice increases energy expenditure and insulin sensitivity and delays fat absorption.
Acyl-CoA synthetase long-chain 5 genotype is associated with body composition changes in response to lifestyle interventions in postmenopausal women with overweight and obesity: a genetic association study on cohorts Montréal-Ottawa New Emerging Team, and Complications Associated with Obesity.
An Essential Role of the N-Terminal Region of ACSL1 in Linking Free Fatty Acids to Mitochondrial ?-Oxidation in C2C12 Myotubes.
Cloning of wrinkle-free, a previously uncharacterized mouse mutation, reveals crucial roles for fatty acid transport protein 4 in skin and hair development.
Diet and Exercise Training Influence Skeletal Muscle Long-Chain acyl-CoA Synthetases.
Expression of fatty-acid-handling proteins in human adipose tissue in relation to obesity and insulin resistance.
Fatty acid transport protein-2 regulates glycemic control and diabetic kidney disease progression.
Fatty acid transport proteins and insulin resistance.
Increased rates of fatty acid uptake and plasmalemmal fatty acid transporters in obese Zucker rats.
Lack of myeloid Fatp1 increases atherosclerotic lesion size in Ldlr
Liver fatty acid-binding protein gene-ablated female mice exhibit increased age-dependent obesity.
Long chain acyl CoA synthetase 1 and gelsolin are oppositely regulated in adipogenesis and lipogenesis.
Mice deleted for Fatty Acid transport protein 5 have defective bile Acid conjugation and are protected from obesity.
Mitochondrial remodeling in mice with cardiomyocyte-specific lipid overload.
SUMO-Specific Protease 2 (SENP2) Is an Important Regulator of Fatty Acid Metabolism in Skeletal Muscle.
The signaling mechanisms of hippocampal endoplasmic reticulum stress affecting neuronal plasticity-related protein levels in high fat diet-induced obese rats and the regulation of aerobic exercise.
Trans-resveratrol induces a potential anti-lipogenic effect in lipopolysaccharide-stimulated enterocytes.
Obesity, Abdominal
Fatty acid handling protein expression in adipose tissue, fatty acid composition of adipose tissue and serum, and markers of insulin resistance.
Ovarian Neoplasms
Systematic Analysis of Gene Expression Alterations and Clinical Outcomes for Long-Chain Acyl-Coenzyme A Synthetase Family in Cancer.
Overweight
Acyl-CoA synthetase long-chain 5 genotype is associated with body composition changes in response to lifestyle interventions in postmenopausal women with overweight and obesity: a genetic association study on cohorts Montréal-Ottawa New Emerging Team, and Complications Associated with Obesity.
Skeletal muscle fatty acid transporter protein expression in type 2 diabetes patients compared with overweight, sedentary men and age-matched, endurance-trained cyclists.
Pancreatic Neoplasms
LOX and ACSL5 as potential relapse markers for pancreatic cancer patients.
Peroxisomal Disorders
A mouse model for X-linked adrenoleukodystrophy.
cDNA cloning and mRNA distribution of a mouse very long-chain acyl-CoA synthetase.
Photosensitivity Disorders
Photodynamic effects of antioxidant substituted porphyrin photosensitizers on gram-positive and -negative bacterial.
Poliomyelitis
Increased long chain acyl-Coa synthetase activity and fatty acid import is linked to membrane synthesis for development of picornavirus replication organelles.
Premature Birth
Fatty acid transport protein 1 can compensate for fatty acid transport protein 4 in the developing mouse epidermis.
Requirement of fatty acid transport protein 4 for development, maturation, and function of sebaceous glands in a mouse model of ichthyosis prematurity syndrome.
Primary Ovarian Insufficiency
Activity of Long-Chain Acyl-CoA Synthetase Is Required for Maintaining Meiotic Arrest in Xenopus laevis.
Acyl-CoA synthetase long-chain family member 6 is associated with premature ovarian failure.
Prostatic Neoplasms
A Role of the Heme Degradation Pathway in Shaping Prostate Inflammatory Responses and Lipid Metabolism.
ACSL3 promotes intratumoral steroidogenesis in prostate cancer cells.
Expression and vitamin D(3) regulation of long-chain fatty-acid-CoA ligase 3 in human prostate cancer cells.
Expression of Long-chain Fatty Acyl-CoA Synthetase 4 in Breast and Prostate Cancers Is Associated with Sex Steroid Hormone Receptor Negativity.
Long-Chain Acyl-CoA Synthetase 4-Mediated Fatty Acid Metabolism Sustains Androgen Receptor Pathway-Independent Prostate Cancer.
Long-chain fatty acyl-CoA synthetase 1 promotes prostate cancer progression by elevation of lipogenesis and fatty acid beta-oxidation.
Targeting Oct1 genomic function inhibits androgen receptor signaling and castration-resistant prostate cancer growth.
The role of long-chain fatty-acid-CoA ligase 3 in vitamin D3 and androgen control of prostate cancer LNCaP cell growth.
Vitamin D3 inhibits fatty acid synthase expression by stimulating the expression of long-chain fatty-acid-CoA ligase 3 in prostate cancer cells.
Pulmonary Disease, Chronic Obstructive
Can high-intensity interval training improve physical and mental health outcomes? A meta-review of 33 systematic reviews across the lifespan.
Renal Insufficiency, Chronic
FATP2-targeted therapies - A role beyond fatty liver disease.
Reperfusion Injury
Inhibition of long chain fatty acyl-CoA synthetase (ACSL) and ischemia reperfusion injury.
Retinal Degeneration
Fatty acid transport proteins in disease: New insights from invertebrate models.
Retinal Dystrophies
Inverse correlation between fatty acid transport protein 4 and vision in Leber congenital amaurosis associated with RPE65 mutation.
Retinoblastoma
Identification of novel lipid droplet factors that regulate lipophagy and cholesterol efflux in macrophage foam cells.
Rhabdomyosarcoma
The endogenous subcellular localisations of the long chain fatty acid-activating enzymes ACSL3 and ACSL4 in sarcoma and breast cancer cells.
Sarcoma
Identification of novel lipid droplet factors that regulate lipophagy and cholesterol efflux in macrophage foam cells.
The endogenous subcellular localisations of the long chain fatty acid-activating enzymes ACSL3 and ACSL4 in sarcoma and breast cancer cells.
Sepsis
Long-Chain Acyl-CoA Synthetase 1 Role in Sepsis and Immunity: Perspectives From a Parallel Review of Public Transcriptome Datasets and of the Literature.
Skin Abnormalities
Elevation of blood lipids in hepatocyte-specific fatty acid transport 4-deficient mice fed with high glucose diets.
Keratinocyte-specific expression of fatty acid transport protein 4 rescues the wrinkle-free phenotype in Slc27a4/Fatp4 mutant mice.
Starvation
Effect of starvation on hepatic acyl-CoA synthetase, carnitine palmitoyltransferase-I, and acetyl-CoA carboxylase mRNA levels in rats.
Fatty acid uptake in Escherichia coli: regulation by recruitment of fatty acyl-CoA synthetase to the plasma membrane.
Triacylglycerol synthesis in the oleaginous yeast Candida curvata D.
Stomach Neoplasms
ONECUT2 upregulation is associated with CpG hypomethylation at promoter-proximal DNA in gastric cancer and triggers ACSL5.
Tumor-suppressive functions of long-chain acyl-CoA synthetase 4 in gastric cancer.
Stroke
Inhibition of Acyl-CoA Synthetase Long-Chain Family Member 4 Facilitates Neurological Recovery After Stroke by Regulation Ferroptosis.
Thymoma
Characterization of an arachidonic acid-selective acyl-CoA synthetase from murine T lymphocytes.
Triple Negative Breast Neoplasms
ACSL family: The regulatory mechanisms and therapeutic implications in cancer.
Regulatory mechanisms leading to differential Acyl-CoA synthetase 4 expression in breast cancer cells.
Tuberculosis
Attenuation of Mycobacterium tuberculosis functionally disrupted in a fatty acyl-coenzyme A synthetase gene fadD5.
Dissecting the role of critical residues and substrate preference of a Fatty Acyl-CoA Synthetase (FadD13) of Mycobacterium tuberculosis.
Long-Chain Fatty Acyl Coenzyme A Ligase FadD2 Mediates Intrinsic Pyrazinamide Resistance in Mycobacterium tuberculosis.
Solution and Membrane Interaction Dynamics of Mycobacterium tuberculosis Fatty Acyl-CoA Synthetase FadD13.
The Mycobacterium tuberculosis very-long-chain fatty acyl-CoA synthetase: structural basis for housing lipid substrates longer than the enzyme.
Ureteral Obstruction
Involvement of FATP2-mediated tubular lipid metabolic reprogramming in renal fibrogenesis.
Urinary Bladder Neoplasms
Levels of acyl-coenzyme A synthetase 5 in urothelial cells and corresponding neoplasias reflect cellular differentiation.
Vascular Calcification
Palmitic acid induces osteoblastic differentiation in vascular smooth muscle cells through ACSL3 and NF-?B, novel targets of eicosapentaenoic acid.
Vascular Diseases
Diabetes promotes an inflammatory macrophage phenotype and atherosclerosis through acyl-CoA synthetase 1.
Vesicular Stomatitis
The Lyn kinase C-lobe mediates Golgi export of Lyn through conformation-dependent ACSL3 association.
Vitamin B Deficiency
Maternal micronutrients and omega 3 fatty acids affect placental fatty acid desaturases and transport proteins in Wistar rats.
Wiskott-Aldrich Syndrome
The fadD2 Gene Is Required for Efficient Mycobacterium avium Invasion of Mucosal Epithelial Cells.